For Research

Advances in healthcare are built on medical research, with new discoveries tested and re-tested over time. We're proud to support this critical work: researchers from around the world have used our technology in over 600 peer-reviewed publications, contributing to significant medical breakthroughs and reproducible science. This rigorous process ensures that new findings are not only credible but can be reliably built upon to enhance patient care worldwide.

Nightingale’s technology has been used to analyze more than two million samples, including world-leading open-access resources like the UK Biobank. We are the only 'omics measured on every sample in the UK Biobank's extensive cohort, enabling studies into cardiovascular diseases, diabetes, liver diseases, kidney diseases, lung diseases, aging, cancer, and more, paving the way for breakthroughs in prevention and care.

This foundation of peer-reviewed research and analysis of massive patient cohorts has enabled the development of highly precise disease risk predictions. Because Nightingale's technology is clinically validated, the path from discovery to translation of those predictions has been dramatically shortened, and is in use to manage chronic diseases today. The research-based origins of our technology live today as tangible solutions utilized in national healthcare.